Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cowen & Co. Downgrades Imago BioSciences to Market Perform, Announces $36 Price Target

Author: Benzinga Newsdesk | November 22, 2022 06:31am

Cowen & Co. analyst Marc Frahm downgrades Imago BioSciences (NASDAQ:IMGO) from Outperform to Market Perform and announces $36 price target.

Posted In: IMGO